Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PNEUMA: Partial Neuromuscular Blockade in Acute Hypoxemic Respiratory Failure
NCT04524585Recruiting
- Sponsor
- University Health Network
- Start
- Oct 2020
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cisatracurium in acute hypoxemic respiratory failure (AHRF), sponsored by University Health Network. Primary endpoint: Rate of patients achieving and maintaining targeted expiratory occlusion pressure (Pocc) at 48 hours. Started Oct 2020; status: recruiting.
02
Drugs
cisatracurium
03
Conditions
acute hypoxemic respiratory failure (AHRF)
Beyond the preview
Go deeper on NCT04524585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04524585.